# Immune Checkpoint Inhibitor Therapy- Induced Endocrinopathy

> **NCT04079647** · — · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Endocrinopathy

## Interventions

- **DRUG:** Immunotherapy

## Key facts

- **NCT ID:** NCT04079647
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-03
- **Primary completion:** 2025-07-01
- **Final completion:** 2025-07-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2019-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04079647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04079647, "Immune Checkpoint Inhibitor Therapy- Induced Endocrinopathy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04079647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*